South Korean court Rules Government Liable for Disability Following AstraZeneca Vaccine
A Seoul court has mandated government compensation for a man in his 20s who developed a debilitating neurological condition shortly after receiving the AstraZeneca (AZ) COVID-19 vaccine, marking a significant legal precedent regarding vaccine-related injuries. The ruling underscores the growing debate surrounding causality and duty in the wake of global vaccination campaigns.
The case, heard by the 8th Administrative Division of the Seoul Administrative Court on Thursday, centered on Mr.A, who experienced a range of adverse reactions – including fever, vomiting, and muscle pain – approximately 10 hours after vaccination in March 2021. He was later diagnosed with ‘unspecified encephalitis, myelitis, and encephalomyelitis’ and later, in 2023, with Guillain-Barré syndrome, a rare and serious autoimmune disorder.
Initially denied compensation under Article 71 of the Infectious Disease Prevention Act, Mr. A’s claims were repeatedly rejected by the Korea Disease Control and Prevention Agency (KDCA). Despite this,the Ministry of Health and welfare provided 26.54 million won (approximately $20,000 USD) in medical expense support through a program for diseases suspected to be linked to COVID-19 vaccination. Mr.A argued that the denial of full compensation was unjust, citing the temporal proximity between his vaccination and the onset of his debilitating symptoms.
“The adverse reactions,such as gait disturbance and myelitis,are temporally close to the COVID-19 vaccination,and there are no circumstances that can be attributed to other causes,” Mr.A asserted in his lawsuit.
The KDCA countered that Mr. A had already received financial assistance and that further compensation was unnecessary, arguing that the support project adequately addressed his medical needs. However, the court dismissed this argument, stating that the medical expense support project was capped at 50 million won and lacked a firm legal basis as a permanent solution.
The court’s decision hinged on a key principle of causality, referencing a Supreme Court precedent that establishes a strong inference of connection when a close temporal relationship exists between vaccination and the development of a disability, unless other plausible causes are identified. the court emphasized that proving the disability wasn’t caused by an unknown or unrelated factor is sufficient to establish a link.
Moreover, the court considered Mr. A’s age – 25 at the time of vaccination – his previously unblemished health record, and his role as an occupational therapist actively contributing to national quarantine efforts. This context, the court reasoned, reinforced the state’s obligation to consider compensation for a disability incurred while cooperating with public health measures.
Critically, the ruling also challenges the KDCA’s internal standards for evaluating vaccine injury claims. The court found that the agency’s systematic denial of causality in cases categorized as having “insufficient data” (category 4-1) represented a misinterpretation of existing Supreme Court rulings. The court stated there is “a high possibility that a causal relationship is inferred for diseases suspected of being related,for which credible institutions at home and abroad have raised the possibility of statistical correlation.”
This decision is expected to prompt a reevaluation of the KDCA’s compensation review process and perhaps open the door for similar claims from individuals experiencing adverse health outcomes following COVID-19 vac
